Markus Reitmajer

11PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 08, 2026
Cancer survivorship in malignant melanoma.

|Sep 07, 2026
Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020.

|Dec 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival.

Axel Gschwind, Nadja Ballin, Alexander Ott

|Nov 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Markus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling

|Oct 13, 2025
Precision medicine in cutaneous melanoma-A comprehensive review.

Markus Reitmajer, Lukas Flatz

|Apr 25, 2025
Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire study.

Markus Reitmajer, Norbert Schäffeler, Anne Bach

Pageof 2

Frequent Collaborators

7 joint publications

Andrea Forschner

3 joint publications

Frank Meiss

2 joint publications

Ulrike Leiter

1 joint publications

Stephan Forchhammer